FDA Inspection 678112 — Targos Molecular Pathology Gmbh

Targos Molecular Pathology Gmbh — FEI 3008065775

The FDA completed an inspection of Targos Molecular Pathology Gmbh on Aug 5, 2010 in Kassel. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 5, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Kassel (Germany)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.